Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 18
Phase 22
Phase 31

Trial Status

Completed9

Role Distribution

Other Roles9

Activity Timeline

Clinical Trials (9)

NCT06180083Phase 1Completed
Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray
Perennial Allergic RhinitisSeasonal Allergic Rhinitis
StudydirectorStart date: 2023-03-24
NCT06084663Phase 3Completed
Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects
Psoriasis and Psoriatic Arthritis
StudydirectorStart date: 2023-02-15
NCT05082662Phase 1/2Completed
Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet
AnalgesicAntipyreticNon-steroidal Anti-inflammatory (NSAID)
StudydirectorStart date: 2020-08-25

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT06180070Phase 1StudyDirector

Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol)

BackacheHeadacheMigraine
Completed
NCT06180109Phase 1StudyDirector

Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozin) 25 mg Film-coated Tablets of Boehringer Ingelheim International GmbH, Germany in Normal, Healthy, Adult, Human Subjects Under Fasting Condition

Type2 Diabetes Mellitus
Completed
NCT06180083Phase 1StudyDirector

Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

Perennial Allergic RhinitisSeasonal Allergic Rhinitis
Completed
NCT06043297Phase 1StudyDirector

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

Antithrombic Drug
Completed
NCT06084663Phase 3StudyDirector

Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects

Psoriasis and Psoriatic Arthritis
Completed
NCT06180057Phase 1StudyDirector

Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid)

Cerebrotendinous Xanthomatoses
Completed
NCT04817800Phase 1/2StudyDirector

To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray

Seasonal Allergic Rhinitis
Completed
NCT05082753Phase 1StudyDirector

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Anthelmintic Agent
Completed
NCT05082662Phase 1/2StudyDirector

Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet

AnalgesicAntipyreticNon-steroidal Anti-inflammatory (NSAID)
Completed

All 9 trials loaded